搜索临床试验以:lisdexamfetamine dimesylate (SPD489)
总计1324个结果
-
King Faisal Specialist Hospital & Research Center完全的
-
Centre Leon BerardGustave Roussy, Cancer Campus, Grand Paris完全的
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.招聘中
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC完全的
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Novartis Pharmaceuticals完全的CHRONIC MYELOGENOUS LEUKEMIA加拿大, 澳大利亚, 西班牙, 阿根廷, 法国, 巴西
-
University of California, San FranciscoNational Cancer Institute (NCI)完全的
-
Queen Mary University of LondonGlaxoSmithKline未知
-
Jan BeumerNovartis Pharmaceuticals完全的
-
National Cancer Institute (NCI)完全的
-
Poitiers University HospitalNovartis; Ministry of Health, France终止
-
Novartis Pharmaceuticals完全的
-
Peking University People's HospitalPeking University Shougang Hospital; Peking University International Hospital撤销
-
Beth Israel Deaconess Medical CenterMedical University of South Carolina; Massachusetts General Hospital; National Institute of Neurological... 和其他合作者完全的
-
Bristol-Myers Squibb终止
-
Centre Leon Berard招聘中
-
Alexandria UniversityScience, Technology & Innovation Funding Authority (STIFA), Egypt未知
-
Memorial Sloan Kettering Cancer Center终止
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital终止